MedPath

Development of a low-dose mammography technique to calculate women’s breast density to aid breast cancer risk assessment

Not Applicable
Suspended
Conditions
Risk assessment of young women for breast cancer using automated low dose risk assessment mammography
Cancer
Registration Number
ISRCTN55983830
Lead Sponsor
Manchester University NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Female
Target Recruitment
600
Inclusion Criteria

1. Women aged between 30 and 45 years
2. Moderate to high risk of developing breast cancer
3. Capable of providing informed consent to a participant information sheet written in English

Exclusion Criteria

1. Prior breast cancer
2. Prior breast augmentation or reduction (this does not include those who have had breast surgery for a benign condition)
3. Participation in the TARA-Prev study which included an additional mammogram and thus radiation dose

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation between Mammographic density assessed as predicted VAS (visual assessment score) on the full dose and low dose mammograms measured using an artificial intelligence-driven algorithm for automated measurement on Full Field Digital Mammography (FFDM) and low dose counterpart from the raw mammography image files at a single time point
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath